(2023) revealed that the blood inflammatory parameters including C-reactive protein (CRP) and neutrophil-to-lymphocyte ratio (NLR) could be employed as predictors for hematoma expansion and ICH prognosis. The gene discussed is CRP; the disease is hematoma.